Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
213.14
-0.59 (-0.28%)
Nov 26, 2025, 4:00 PM EST - Market closed
Cardinal Health Stock Forecast
Stock Price Forecast
The 11 analysts that cover Cardinal Health stock have a consensus rating of "Buy" and an average price target of $196.36, which forecasts a -7.87% decrease in the stock price over the next year. The lowest target is $145 and the highest is $225.
Price Target: $196.36 (-7.87%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cardinal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 3 | 3 |
| Buy | 6 | 6 | 7 | 7 | 7 | 6 |
| Hold | 4 | 4 | 4 | 4 | 4 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 14 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $185 → $221 | Buy | Maintains | $185 → $221 | +3.69% | Nov 5, 2025 |
| Mizuho | Mizuho | Buy Maintains $170 → $210 | Buy | Maintains | $170 → $210 | -1.47% | Nov 4, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $183 → $225 | Strong Buy | Maintains | $183 → $225 | +5.56% | Nov 3, 2025 |
| Citigroup | Citigroup | Hold Maintains $165 → $190 | Hold | Maintains | $165 → $190 | -10.86% | Oct 31, 2025 |
| UBS | UBS | Strong Buy Maintains $185 → $220 | Strong Buy | Maintains | $185 → $220 | +3.22% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
256.54B
from 222.58B
Increased by 15.26%
Revenue Next Year
277.95B
from 256.54B
Increased by 8.34%
EPS This Year
9.72
from 6.45
Increased by 50.75%
EPS Next Year
10.98
from 9.72
Increased by 12.91%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 274.4B | 304.5B | |||
| Avg | 256.5B | 277.9B | |||
| Low | 242.8B | 260.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 23.3% | 18.7% | |||
| Avg | 15.3% | 8.3% | |||
| Low | 9.1% | 1.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.58 | 11.90 | |||
| Avg | 9.72 | 10.98 | |||
| Low | 9.18 | 10.33 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 64.1% | 22.3% | |||
| Avg | 50.8% | 12.9% | |||
| Low | 42.4% | 6.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.